About IMMUSOFT CORP
Immusoft is the world leader in engineering B cells as biofactories for therapeutic protein delivery, using its proprietary Immune System Programming (ISP™) platform to develop personalized protein therapeutics for patients.
Engineering B cells as biofactories for therapeutic protein deliveryProgramming B cells to produce personalized protein therapeuticsExpanding and differentiating B cells into plasma cells for therapeutic protein productionInfusing programmed cells back into patients for extended therapeutic protein production
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IMMUSOFT CORP right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.